Attention javascript est désactivé sur votre poste.
Ce site nécessite l'activation de javascript pour fonctionner correctement.
Also learn about Oncodesign Services, dedicated to CRO activities in Drug Discovery
Learn more
Also learn about Oncodesign Services, dedicated to CRO activities in Drug Discovery
Learn more
Our pipeline
Partnering
Our innovation technologies
OncoSNIPER
Nanocyclix
PROMETHE
Investors
Message from the chairman
Regulated information [FR]
Press Release
About us
Latest news
Our history
Management
Our HR policy
Our CSR approach
FederAidd
Contact us
The latest news of OPM are here
Subscribe to the OPM newsletter
Subscribe to the OPM newsletter
All
Financial
News
Poster
Press Release
Scientific paper
Uncategorized
Filter by :
All
Financial
News
Poster
Press Release
Scientific paper
Uncategorized
Poster
Tue. 1 September 2020
NANOCYCLIX® ALK2 INHIBITORS TO OVERCOME CANCER INDUCED ANEMIA
Read more
Scientific paper
Mon. 7 October 2019
Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells
Read more
1
2
3